Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed early-phase tilt small index

Stage IV Uterine Corpus Cancer: early-phase trial registry

A small indexed set (5 trials) with no open enrollment listed right now.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

Browse conditions → How counts are built

5 US clinical trials · none currently recruiting · #3,391 of 28,707 conditions by registered trial count

Stage IV Uterine Corpus Cancer: 5 US clinical trials tracked, none currently recruiting.

Stage IV Uterine Corpus Cancer is the subject of 5 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Gynecologic Oncology Group, running 5 of these trials.

Enrollment posture brief

Registry condition stage-iv-uterine-corpus-cancer

OPEN 0 | RECR 0% | LATE 0 | EARLY 1 | RANK #3391 | SPON 5

Volume-matched condition peers

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Stage IV Uterine Corpus (th…0%
Open-enrollment share among volume-matched conditions near Stage IV Uterine Corpus Cancer

Stage IV Uterine Corpus Cancer has no open enrollment in this registry pull (5 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Stage IV Uterine Corpus Cancer on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Stage IV Uterine Corpus Cancer is recruiting below its size-band peers.

    0 of 5 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Stage IV Uterine Corpus Cancer research.

    Gynecologic Oncology Group accounts for 5 of 5 trials (100%). 1 distinct sponsors appear on at least one study for this condition label.

  3. Typical Stage IV Uterine Corpus Cancer enrolment sits around 243 participants.

    Median target enrolment is 243 among the 5 trials that report a genuine target (sentinel values excluded). 1 of those (20%) plan for fewer than 100 participants.

  4. Stage IV Uterine Corpus Cancer research leans observational.

    1 interventional and 4 observational studies make up this index (20% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Top Sponsors

Gynecologic Oncology Group 5 trials

Named interventions

Most-linked intervention names on Stage IV Uterine Corpus Cancer records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Laboratory Biomarker Analysis Other
4 trials
Study of Socioeconomic and Demographic Variables Other
2 trials
Microarray Analysis Genetic
1 trials
Immunohistochemistry Staining Method Other
1 trials
Medroxyprogesterone Drug
1 trials
Diagnostic Laboratory Biomarker Analysis Other
1 trials
Therapeutic Conventional Surgery Procedure
1 trials
Medical Chart Review Other
1 trials

US sites by state

Facility locations filed on Stage IV Uterine Corpus Cancer trials. A trial with sites in several states counts in each.

Pennsylvania 5 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Stage IV Uterine Corpus Cancer page

5 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • No Stage IV Uterine Corpus Cancer trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Gynecologic Oncology Group sponsors the most Stage IV Uterine Corpus Cancer trials on record, review their full trial history before evaluating a specific study. See Gynecologic Oncology Group's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Stage IV Uterine Corpus Cancer condition card totals 5 registered trials; most-linked intervention Laboratory Biomarker Analysis; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.